本页面由Tiger Trade Technology Pte. Ltd.提供服务

Heron Therapeutics Inc.

0.3155
-0.0068-2.11%
盘后0.32180.0063+2.00%19:30 EDT
成交量:137.17万
成交额:44.00万
市值:5,962.95万
市盈率:-1.71
高:0.3312
开:0.3300
低:0.3114
收:0.3223
52周最高:1.58
52周最低:0.2975
股本:1.89亿
流通股本:1.47亿
量比:0.96
换手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-0.1842
每股收益(LYR):-0.1211
净资产收益率:-2408.88%
总资产收益率:-2.80%
市净率:10.18
市盈率(LYR):-2.60

数据加载中...

2023/03/06

重要事件披露

8-K - Current report
2023/02/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/22

重要事件披露

8-K - Current report
2023/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/01/31

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/09

重要事件披露

8-K - Current report
2022/12/29

重要事件披露

8-K - Current report
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/13

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/19

重要事件披露

8-K - Current report
2022/09/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report